Taigen Biopharmaceutica (Taiwan) Technical Analysis

4157 Stock  TWD 11.45  0.35  2.97%   
As of the 15th of December 2024, Taigen Biopharmaceutica has the Variance of 2.31, coefficient of variation of (484.32), and Risk Adjusted Performance of (0.14). Taigen Biopharmaceutica technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Taigen Biopharmaceutica mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Taigen Biopharmaceutica is priced more or less accurately, providing market reflects its prevalent price of 11.45 per share.

Taigen Biopharmaceutica Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Taigen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Taigen
  
Taigen Biopharmaceutica's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Taigen Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Taigen Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Taigen Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Taigen Biopharmaceutica Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Taigen Biopharmaceutica volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Taigen Biopharmaceutica Trend Analysis

Use this graph to draw trend lines for Taigen Biopharmaceuticals Holdings. You can use it to identify possible trend reversals for Taigen Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Taigen Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Taigen Biopharmaceutica Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Taigen Biopharmaceuticals Holdings applied against its price change over selected period. The best fit line has a slop of   0.06  , which may suggest that Taigen Biopharmaceuticals Holdings market price will keep on failing further. It has 122 observation points and a regression sum of squares at 137.16, which is the sum of squared deviations for the predicted Taigen Biopharmaceutica price change compared to its average price change.

About Taigen Biopharmaceutica Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Taigen Biopharmaceuticals Holdings on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Taigen Biopharmaceuticals Holdings based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Taigen Biopharmaceutica price pattern first instead of the macroeconomic environment surrounding Taigen Biopharmaceutica. By analyzing Taigen Biopharmaceutica's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Taigen Biopharmaceutica's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Taigen Biopharmaceutica specific price patterns or momentum indicators. Please read more on our technical analysis page.

Taigen Biopharmaceutica December 15, 2024 Technical Indicators

Most technical analysis of Taigen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Taigen from various momentum indicators to cycle indicators. When you analyze Taigen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for Taigen Stock Analysis

When running Taigen Biopharmaceutica's price analysis, check to measure Taigen Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taigen Biopharmaceutica is operating at the current time. Most of Taigen Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Taigen Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taigen Biopharmaceutica's price. Additionally, you may evaluate how the addition of Taigen Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.